Business Context and Reporting Period
Company: Primedex Health Systems, Inc. (Note: The filing text identifies the registrant as Primedex, though the request metadata mentions Radnet, Inc., which is a wholly-owned subsidiary consolidated within Primedex).
Reporting Period: Quarterly period ended January 31, 2006 (Fiscal Q2 2006).
Business Overview: Primedex operates 60 fixed-site freestanding outpatient diagnostic imaging facilities in California, offering MRI, CT, PET, nuclear medicine, mammography, ultrasound, and X-ray services. The company operates as a single segment and relies heavily on a management agreement with Beverly Radiology Medical Group III (BRMG) to provide professional medical services.
Key Financial Metrics
| Metric | Q2 2006 (3 Months) | Q2 2005 (3 Months) |
|---|---|---|
| Net Revenue | $38,538,000 | $34,110,000 |
| Income from Operations | $3,933,000 | $2,013,000 |
| Net Loss | $(477,000) | $(2,198,000) |
| Net Loss Per Share (Basic/Diluted) | $(0.01) | $(0.05) |
| Cash from Operating Activities | $2,504,000 | $1,675,000 |
| Cash and Cash Equivalents (End of Period) | $2,000 | $2,000 |
| Total Assets | $118,585,000 | $121,233,000 |
| Total Liabilities | $189,545,000 | $191,866,000 |
| Stockholders' Deficit | $(70,960,000) | $(70,633,000) |
Debt and Liquidity: As of January 31, 2006, the company reported a working capital deficit of $5.5 million, a significant improvement from a $143.4 million deficit at October 31, 2005. This improvement was largely due to the reclassification of approximately $109 million in notes and capital lease obligations from current to long-term liabilities following a refinancing agreement.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased by 13% ($4.4 million) compared to the prior year quarter. Growth was driven by facility expansions in Temecula and Thousand Oaks, equipment upgrades in Tarzana, and a new capitation arrangement in Modesto.
- Operating Profitability: Income from operations increased by $1.9 million (95% increase) to $3.9 million. Operating expenses as a percentage of revenue decreased from 94.1% to 89.8%.
- Net Loss Reduction: Net loss decreased by $1.7 million (78% reduction) to $0.5 million, primarily due to improved operating income.
- Bad Debt Provision: The provision for bad debts increased by $440,000 to $1.35 million, attributed to increased revenue and changes in payor mix.
- Interest Expense: Interest expense increased slightly by $226,000 to $4.46 million due to higher borrowings on lines of credit and rising prime rates.
Guidance, Outlook, Risks, and Subsequent Events
Subsequent Event: Major Refinancing
Effective March 9, 2006, the company completed a $161 million senior secured credit facility to refinance substantially all existing indebtedness. The facility includes:
- $15 million five-year revolving credit facility.
- $86 million term loan due in five years.
- $60 million second lien term loan due in six years.
This refinancing allowed the company to reclassify the majority of its debt as non-current, significantly improving working capital. The loans are subject to acceleration on December 27, 2007, unless subordinated debentures are discharged or extended.
Regulatory Risks (Deficit Reduction Act of 2005)
The Deficit Reduction Act (DRA), signed into law on February 9, 2006, caps Medicare reimbursement for technical components of imaging services at the lower of the Part B physician fee schedule or the Hospital Outpatient Prospective Payment System (HOPPS) schedule, effective January 1, 2007. The company estimates this could reduce revenue by $2.5 million to $3.0 million annually if applied to fiscal 2005 levels.
Management Outlook
Management believes that through strategic plans and the new refinancing structure, the company will generate sufficient cash to satisfy obligations for the next twelve months. The strategy focuses on maximizing facility performance, profitable contracting, and expanding MRI/CT applications.
Internal Control Weakness
Management identified a material weakness in internal controls over financial reporting due to insufficient personnel resources and technical accounting expertise for non-routine matters. Remediation efforts are underway, including consulting with outside resources and hiring qualified personnel.
Investor Verification Checklist
- Debt Covenant Compliance: Verify the company's ability to meet the new financial covenants (leverage ratios, fixed charge coverage) under the March 9, 2006 credit facility.
- Medicare Reimbursement Impact: Assess the actual financial impact of the Deficit Reduction Act (DRA) on revenue starting January 1, 2007, particularly for MRI and CT services.
- BRMG Relationship: Monitor the stability of the management agreement with Beverly Radiology Medical Group III (BRMG), which provides professional services at 42 of 60 facilities.
- Internal Control Remediation: Confirm the successful remediation of the identified material weakness in accounting for non-routine transactions by the end of fiscal 2006.
- Subordinated Debentures: Track the company's progress in retiring or extending the $16.1 million in subordinated debentures to avoid acceleration of the new term loans in December 2007.